2015 World STI & HIV Congress and Australasian HIV&AIDS Conference
Educational Workshops

One Day Science Symposium - Sevgi Aral, Centre for Disease Control and Prevention & James Blanchard, University of Manitoba
Date:         Sunday 13 September 2015
Time:         8.30am - 5.00pm
Location:  Room P1 Brisbane Convention & Exhibition Centre
Cost:          Complimentary  

Queensland Community PrEP Forum
On Tuesday evening from 6:00pm – 8:00pm, the HIV Foundation Queensland is hosting a Community PrEP Forum being held at the Brisbane Convention Centre.

This is a free event open to the public and Heath Paynter from the Victorian AIDS Council will be facilitating the event. 

PrEP in Australia and Queensland: Find out about options for access and costs now and plans for the future – Dr Darren Russell

PrEP in San Francisco: Hear about the social and cultural power of PrEP and how it has changed HIV in San Francisco from the man who led the way – Prof. Bob Grant

What’s it like to be on PrEP: Your chance to hear directly from someone about their experience of what it’s like.

Get your questions answered: The speakers will form a panel with GP, Dr Fiona Bisshop for an interactive discussion to answer any questions you may have on PrEP. View the Forum flyer

HIV prevention has changed.

Come to the forum to find out more.

Penelope Lowe Trainee Breakfast
Date:         Wednesday 16 September 2015
Time:         7.00am - 8.45am
Location:  Brisbane Convention & Exhibition Centre
Cost:         $33.00 

AFAO Community and Advocacy Hub: call for community videos and posters
The Australian Federation of AIDS Organisations (AFAO) will once again be hosting a Community and Advocacy Hub at the 2015 Australasian HIV & AIDS Conference.

The Hub is a dynamic community space which will highlight programs, services and key focus areas for organisations involved in Australia’s community response to HIV.

The Hub will also feature a selection of HIV/STI-related short films and health promotion resources from community organisations working across Australia and the Asia-Pacific region.

AFAO is pleased to invite community organisations and groups to submit short films and posters for display. Expression of interest should be sent to Finn O’Keefe at AFAO by 31 August. 

Email: fokeefe@afao.org.au.au  or for further information see: http://bit.ly/1DQVIN3

Satellite Meetings

Gates Foundation Satellite 
Date:         Sunday 13 September 2015
Time:         1.30pm - 3.00pm
Location:  Brisbane Convention & Exhibition Centre
Cost:          Complimentary  

World Health Organisation Satellite
Date:         Sunday 13 September 2015
Time:         3.30pm - 5.00pm
Location:  Brisbane Convention& Exhibition Centre
Cost:         Complimentary 

Roche Satellite
Date:         Monday 14 September 2015
Time:         7.30am - 9.00am
Location:  Brisbane Convention& Exhibition Centre
Cost:         Complimentary 

Hologic Satellite
Date:         Tuesday 15 September 2015
Time:         7.30am - 9.00am
Location:  Brisbane Convention & Exhibition Centre
Cost:         Complimentary 

ViiV Satellite
Date:         Wednesday 16 September 2015
Time:         7.00am - 8.45am
Location:  Brisbane Convention& Exhibition Centre
Cost:         Complimentary 

Gilead Satellite #Wheretonext
Date:         Thursday 17 September 2015
Time:         6.15pm - 8.30pm
Location:   Brisbane Convention & Exhibition Centre
Cost:           Complimentary 

As HIV treatment options continue to change and evolve, it is time to challenge existing thinking, apply scientific innovation and ensure the best patient outcomes are achieved with the treatments we have available today.  This is the aim of the Gilead Symposium.  The first presentation, by Professor Andrew Carr, will focus on single tablet regimens and ask the question: is this regimen for a lifetime?  The second presentation, by Professor Darren Russell, will focus on using existing treatments as prevention; how can we make the playground safer? Finally, Rubern Meehan will highlight how innovative thinking, and application of scientific investigation might deliver outcomes beyond today’s expectations. #wheretonext?

External Associated Events

Control and Elimination within Australia to Hepatitis C from People living with HIV (CEASE)
Treatments for Hepatitis C with Direct Acting Antivirals: Training for HIV prescribers 

Hepatitis C has long been recognised as a major contributor to co-morbidity in people living with HIV. The HIV-HCV coinfected population is at high risk of accelerated progression to end stage liver disease, liver cancer and associated death. The availability of low toxicity directly acting antiviral drugs (DAA) is likely to revolutionise the potential for treatment on both an individual and population level basis, and are likely to be equally successful in HIV positive and negative individuals. Prescription of these regimens need to move from the specialist liver clinic to community based prescribers if large scale access to treatment is to be achieved. 

This one-day course is designed for current HIV prescribers in order to up-skill the primary care based workforce to broaden their clinical role in management of HIV/HCV co-infection into management of HCV mono-infection. Topics to be covered include: information about the CEASE project; emerging therapies; their timelines and implications for treatment decision making; DAAs for HIV/HCV co-infection; assessment of liver disease; and more. 

Date: Saturday 19 September 2015 
Time: 9.00am - 5.00pm 
Venue: TBC Brisbane
For further information and registration please see www.ashm.org.au/courses